Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Sanofi Pasteur MSD Limited
Mallards Reach, Bridge Avenue, Maidenhead, Berkshire, SL6 1QP
Telephone: +44 (0)1628 785 291
Fax: +44 (0)1628 671 722
Medical Information Direct Line: +44 (0)1628 587 693
Medical Information e-mail: medinfo@spmsd.com
Medical Information Fax: +44 (0)1628 635 072

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 22/05/2012
PIL MMRVAXPRO

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 22/05/2012 and displayed until Current
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
  • Change to date of revision
  • Change to side-effects
Updated on 04/07/2011 and displayed until 22/05/2012
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Removal of Black Triangle
Updated on 21/05/2010 and displayed until 04/07/2011
Reasons for adding or updating:
  • Change to information for healthcare professionals
  • Change to how the medicine works
  • Change to date of revision
Updated on 05/12/2008 and displayed until 21/05/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to, or new, use for medicine
  • Change to MA holder contact details
Updated on 07/07/2008 and displayed until 05/12/2008
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  measles, mumps and rubella vaccine (live)